RMTG (Regenerative Medical Technology Group) Margin of Safety % (DCF Dividends Based): N/A (As of Jul. 25, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

RMTG Regenerative Medical Technology Group Inc RMTG
26 GF Score
Price $0.09
GF Value $0.06
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Regenerative Medical Technology Group Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

Regenerative Medical Technology Group's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Dividends Based) is not calculated.

RMTG vs PTIX, CERO, EMMA: Margin of Safety % (DCF Dividends Based) Comparison

For the Biotechnology subindustry, Regenerative Medical Technology Group's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Regenerative Medical Technology Group Margin of Safety % (DCF Dividends Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Regenerative Medical Technology Group's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where Regenerative Medical Technology Group's Margin of Safety % (DCF Dividends Based) falls into.


RMTG
26GF Score
Regenerative Medical Technology Group Inc RMTG
Margin of Safety % (DCF Dividends Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Regenerative Medical Technology Group (RMTG) Overvalued in 2026?

Based on GuruFocus' analysis, Regenerative Medical Technology Group stock appears to be overvalued. The current stock price of $0.09 is trading 58.2% above its estimated GF Value™ of $0.06. GuruFocus considers Regenerative Medical Technology Group to be Significantly Overvalued.

Key valuation signals for RMTG:

  • Margin of Safety % (DCF Dividends Based): N/A
  • GF Value™: $0.06 vs. price of $0.09 (58.2% above fair value)
  • GF Score™: 26/100 with 6 warning signs

No single metric tells the full story. See the RMTG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Regenerative Medical Technology Group Business Description

Address 433 Plaza Real, Suite 275, Boca Raton, FL, USA, 33432
Regenerative Medical Technology Group Inc is engaged in the regenerative medicine business through its subsidiary, Global Stem Cells Group. The company provides stem cell therapies, exosomes, peptides, biologics, physician training and certifications, diagnostic tools, and related clinical support services. It operates through one reportable segment, Global Stem Cells Group.
26GF Score

Get the complete analysis for RMTG

Margin of Safety % (DCF Dividends Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.09
Price
$0.06
GF Value